We found nine ABCA4 novel variants in eight unrelated patients with STGD clinical phenotypes (Figure 3); eight were considered as likely pathogenic/pathogenic, and one as VUS (Table 1). This evidence concerns the gene ABCA4 and severe early-childhood-onset retinal dystrophy.